专利号:WO-2021074309-A1 优先权日:2019-10-16 标 题:1-(3-quinolyl)-3,4-dihydroisoquinoline derivatives as fungicides for combating specific phytopathogens 发明人:WEISS MATTHIAS; QUARANTA LAURA; BOU HAMDAN FARHAN; MAHAJAN ATUL; WILLIAMS SIMON; KILARU JAGADEESH; SEN INDIRA; BIERI STEPHANE; DIGGELMANN MARTIN 权利人:SYNGENTA CROP PROTECTION AG 摘要:1-(3-quinolyl)-3,4-dihydroisoquinoline derivatives of formula (I) as well as a method of combating, preventing or controlling the phytopathogens Mycosphaerella graminicola (Septoria tritici), Fusarium culmorum, Gibberella zeae (Fusarium graminearum) and Monographella nivalis (Microdochium nivale), which comprises applying to the phytopathogen, to the locus of the phytopathogen, or to a plant susceptible to attack by the phytopathogen, or to propagation material thereof, a fungicidally effective amount of a 1-(3-quinolyl)-3,4-dihydroisoquinoline derivative of formula (I). The present description discloses the synthesis of exemplary compounds, formulation examples, relevant biological data (antifungal activity against Mycosphaerella graminicola (Septoria tritici), Fusarium culmorum, Gibberella zeae (Fusarium graminearum) and Monographella nivalis (Microdochium nivale) when spayed on plants), as well as comparative data against three prior art compounds (e.g. pages 52 to 85; formulation examples; examples A1 to A3; table E; compounds E.01 to E.187; biological examples). Exemplary compounds are e.g.: 5-bromo-1-(8-fluoro-3-quinolyl)spiro[4H-isoquinoline-3,1'- cyclopropane] (example A1) 5-bromo-1-(8-fluoro-3-quinolyl)-3,3-dimethyl-4H-isoquinoline (example A2) 1-(8-fluoro-3-quinolyl)-3,3-dimethyl-4H-isoquinoline-5-carbonitrile (example A3)
专利号:WO-2021074311-A1 优先权日:2019-10-16 标题:1-(3-quinolyl)-1,2,3,4-tetrahydroisoquinoline derivatives as fungicides for combating specific phytopathogens 发明人:WEISS MATTHIAS; QUARANTA LAURA; BOU HAMDAN FARHAN; MAHAJAN ATUL; WILLIAMS SIMON; KILARU JAGADEESH; BIERI STEPHANE; DIGGELMANN MARTIN 权利人:SYNGENTA CROP PROTECTION AG 摘要:1-(3-quinolyl)-1,2,3,4-tetrahydroisoquinoline derivatives of formula (I) as well as a method of combating, preventing or controlling the phytopathogens Mycosphaerella graminicola (Septoria tritici), Fusarium culmorum, Gibberella zeae (Fusarium graminearum) and Monographella nivalis (Microdochium nivale), which comprises applying to the phytopathogen, to the locus of the phytopathogen, or to a plant susceptible to attack by the phytopathogen, or to propagation material thereof, a fungicidally effective amount of a 1-(3-quinolyl)-1,2,3,4-tetrahydroisoquinoline derivatives of formula (I). The present description discloses the synthesis of exemplary compounds, formulation examples, relevant biological data (antifungal activity against Mycosphaerella graminicola, Monographella nivalis, Fusarium culmorum and/or Gibberella zeae when spayed on plants) (e.g. pages 47 to 55; examples A1 and A2; compounds E.01 to E.17; table E). An exemplary compounds is e.g.: 3-(5-bromo-3,3-dimethyl-2,4-dihydro-1 H-isoquinolin-1-yl)-8-fluoro- quinoline (example A1)
专利号:US-10335382-B2 优先权日:2013-06-14 标 题:Use of hydrogen sulfide synthesis inhibitors for cancer therapy 发明人:HELLMICH MARK; ZHOU JIA; SZABO CSABA 权利人:HELLMICH MARK; ZHOU JIA; SZABO CSABA; UNIV TEXAS 摘要:In certain aspects the methods comprise administering an inhibitor of hydrogen sulfide biosynthesis, a cystathionine-β-synthase (CBS) inhibitor, or a hydrogen sulfide neutralizing agent to a patient having a cancer associated with elevated production of hydrogen sulfide.
专利号:WO-2021009026-A1 优先权日:2019-07-12 标 题 :Methyl 2-[(4-methoxyimino-tetralin-6-yl]prop-2-enoate derivatives, chromane, isochromane, 6,7,8,9-tetrahydrobenzo[7]annulene, 1h-isobenzofurane and indane analogues thereof, and similar compounds, as agrochemical fungicides 发明人:WEISS MATTHIAS; WILLIAMS SIMON; RENDINE STEFANO; BOU HAMDAN FARHAN; HOFFMAN THOMAS; QUARANTA LAURA 权利人:SYNGENTA CROP PROTECTION AG 摘要:Compounds of formula (I): (Formula (I)) Formula (I) encompasses e.g. tetraline, chromane, isochromane, 6,7,8,9-tetrahydrobenzo[7]annulene, 1H-isobenzofurane and indane derivatives. The compounds of formula (I) are useful as a pesticides, especially as fungicides. The present description discloses the synthesis and characterisation of exemplary compounds as well as biological data thereof (e.g. pages 53 to 78; examples 1 to 10; table T1; compounds 1.1 to 1.54; examples A and B). Preferred compounds are e.g.: Methyl (E)-3-methoxy-2-[(4E)-4-methoxyimino-7-methyl-tetralin-6- yl]prop-2-enoate (example 2; compound 1.6 of table T1): (Formula (A)). Methyl (E)-3-methoxy-2-[(4Z)-4-methoxyiminoisochroman-6-yl]prop-2- enoate (example 6; compound 1.39 of table T1): (Formula (B))
专利号:US-2014315720-A1 优先权日:2012-10-24 标 题 :Polysaccharide ester microspheres and methods and articles relating thereto 发明人:FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY 权利人:CELANESE ACETATE LLC 摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.
1: Novobilský A, Höglund J. First report of closantel treatment failure against Fasciola hepatica in cattle. Int J Parasitol Drugs Drug Resist. 2015 Aug 28;5(3):172-7. doi: 10.1016/j.ijpddr.2015.07.003. eCollection 2015 Dec. 2: Snoj T, Cebulj-Kadunc N, Kobal S. Does closantel in therapeutic doses display thyroid hormone-like activity in sheep? J Vet Pharmacol Ther. 2015 Jun;38(3):297-300. doi: 10.1111/jvp.12188. Epub 2014 Nov 20. doi: 10.3109/10837450.2015.1035725. Epub 2015 Aug 31. doi: 10.1016/j.vetpar.2016.08.009. Epub 2016 Aug 5. doi: 10.1016/j.vetpar.2015.10.029. Epub 2015 Nov 10. doi: 10.1001/jamaophthalmol.2015.191. doi: 10.1038/ja.2015.127. Epub 2015 Dec 16. 9: Solana MV, Mera y Sierra R, Scarcella S, Neira G, Solana HD. In vivo assessment of closantel ovicidal activity in Fasciola hepatica eggs. Exp Parasitol. 2016 Jan;160:49-53. doi: 10.1016/j.exppara.2015.10.010. Epub 2015 Nov 6. doi: 10.1016/j.vetpar.2014.11.016. Epub 2014 Nov 24. doi: 10.1111/jvp.12135. Epub 2014 Jun 6. doi: 10.1016/j.chroma.2014.02.090. Epub 2014 Mar 12. doi: 10.1021/jf4022866. Epub 2013 Aug 30. BMC Ophthalmol. 2016 Nov 29;16(1):207.
合成参考文献
摘要:Veterinariya. Veterinary Science., 75(8)(23), 1998 参考文献:10.1016/s0021-9673(99)00135-1 摘要:Stoev G, Dakova T, Michailova A. Quantitative determination of Closantel residues in milk by high-performance liquid chromatography with fluorescence detection. J Chromatogr A. 1999 Jun 18;846(1-2):383–6. doi: 10.1016/s0021-9673(99)00135-1. 参考文献:10.1023/a:1014214122167 摘要:Keyyu JD, Mahingika HM, Magwisha HB, Kassuku AA. Efficacy of Albendazole and Levamisole against Gastrointestinal Nematodes of Sheep and Goats in Morogoro, Tanzania. Tropical Animal Health and Production. 2002 Mar;34(2):115–20. doi: 10.1023/a:1014214122167. 参考文献:10.1016/j.ijpddr.2015.07.003 摘要:Novobilský A, Höglund J. First report of closantel treatment failure against Fasciola hepatica in cattle. International Journal for Parasitology: Drugs and Drug Resistance. 2015 Dec;5(3):172–7. doi: 10.1016/j.ijpddr.2015.07.003. 参考文献:10.1007/s00436-017-5393-2 摘要:Venjakob PL, Thiele G, Clausen PH, Nijhof AM. Toxocara vitulorum infection in German beef cattle. Parasitol Res. 2017 Mar;116(3):1085–8. doi: 10.1007/s00436-017-5393-2.